Using Constellation Pharmacology to Characterize a Novel α-Conotoxin from
Constellation Pharmacology
DRG neurons
conotoxin
nAChRs
Journal
Marine drugs
ISSN: 1660-3397
Titre abrégé: Mar Drugs
Pays: Switzerland
ID NLM: 101213729
Informations de publication
Date de publication:
29 Feb 2024
29 Feb 2024
Historique:
received:
30
01
2024
revised:
27
02
2024
accepted:
28
02
2024
medline:
27
3
2024
pubmed:
27
3
2024
entrez:
27
3
2024
Statut:
epublish
Résumé
The venom of cone snails has been proven to be a rich source of bioactive peptides that target a variety of ion channels and receptors. α-Conotoxins (αCtx) interact with nicotinic acetylcholine receptors (nAChRs) and are powerful tools for investigating the structure and function of the various nAChR subtypes. By studying how conotoxins interact with nAChRs, we can improve our understanding of these receptors, leading to new insights into neurological diseases associated with nAChRs. Here, we describe the discovery and characterization of a novel conotoxin from
Identifiants
pubmed: 38535458
pii: md22030118
doi: 10.3390/md22030118
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIGMS NIH HHS
ID : GM136430, GM122869, GM48677, GM144719
Pays : United States